Infraclinical Synovitis: What You Need to Know
:
Early Signs of Psoriatic Arthritis: Could Imaging Reveal the Risk?
Psoriatic rheumatism (PR), affecting approximately 30% of individuals with skin psoriasis, is a condition where joint inflammation accompanies the skin manifestations. While skin psoriasis typically precedes PR in adults (occurring in 85% of cases),the onset can vary,with PR sometimes appearing before skin psoriasis,particularly in children (in about half of cases).
The connection between skin psoriasis and PR is well-established,but understanding the transition between the two is an ongoing area of research. A key indicator of this transition is synovitis – inflammation of the joint lining – which, while not a formal diagnostic criterion for PR, is considered a hallmark of the condition. Researchers believe synovitis often precedes the progress of full-blown PR.The possibility that detecting synovitis through imaging techniques like ultrasound or MRI in patients with psoriasis but no joint symptoms could signal an increased risk of developing PR is gaining attention.
A recent systematic review and meta-analysis conducted by a team from the University of Toronto investigated the prevalence of synovitis in individuals with skin psoriasis who had no musculoskeletal complaints. The study analyzed data from 1,593 patients with skin psoriasis (982 men and 611 women, average age 46.7 years), 327 patients with PR (210 men and 117 women, average age 50.2 years), and 686 healthy control subjects (average age 45.7 years).
The analysis revealed that patients with psoriasis were approximately 2.5 times more likely to exhibit infraclinical synovitis (synovitis detected through imaging but not causing noticeable symptoms) compared to the control group (RR 2.55, 95% confidence interval 1.18-5.52). While the presence of synovitis was more frequent in the PR group, this difference was not statistically significant.
These findings suggest that imaging, particularly MRI, can detect early signs of inflammation in the joints of people with psoriasis, even before they experience symptoms. This “infraclinical” synovitis could serve as an early warning sign, potentially allowing for earlier intervention and management to reduce the risk of developing PR. However, further longitudinal studies are needed to confirm the predictive value of this finding and to determine the best course of action for patients identified as being at risk.
This research highlights the importance of a proactive approach to managing psoriasis, with consideration given to early detection of joint inflammation as a potential preventative measure against the development of psoriatic arthritis.
